Works matching AU Pisano, Carmela

Results: 32
    1
    2

    Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9)

    Published in:
    2014
    By:
    • Esposito, Francesca;
    • Cecere, Sabrina Chiara;
    • Magazzino, Francescapaola;
    • Katsaros, Dionyssios;
    • Ottaiano, Alessandro;
    • Gadducci, Angiolo;
    • Pisano, Carmela;
    • Scalone, Simona;
    • Rabaiotti, Emanuela;
    • Salutari, Vanda;
    • Cormio, Gennaro;
    • Canuto, Emilie Marion;
    • Greggi, Stefano;
    • Savarese, Antonella;
    • Marinaccio, Marco;
    • Scollo, Paolo;
    • Santeufemia, Davide Adriano;
    • Sacco, Cosimo;
    • Facchini, Gaetano;
    • Pignata, Sandro
    Publication type:
    Journal Article
    3

    Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9).

    Published in:
    Oncology, 2014, v. 86, n. 5/6, p. 351, doi. 10.1159/000358730
    By:
    • Esposito, Francesca;
    • Cecere, Sabrina Chiara;
    • Magazzino, Francescapaola;
    • Katsaros, Dionyssios;
    • Ottaiano, Alessandro;
    • Gadducci, Angiolo;
    • Pisano, Carmela;
    • Scalone, Simona;
    • Rabaiotti, Emanuela;
    • Salutari, Vanda;
    • Cormio, Gennaro;
    • Canuto, Emilie Marion;
    • Greggi, Stefano;
    • Savarese, Antonella;
    • Marinaccio, Marco;
    • Scollo, Paolo;
    • Santeufemia, Davide Adriano;
    • Sacco, Cosimo;
    • Facchini, Gaetano;
    • Pignata, Sandro
    Publication type:
    Article
    4
    5
    6
    7

    Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 652, doi. 10.1002/cpt.2960
    By:
    • Polano, Maurizio;
    • Bedon, Luca;
    • Dal Bo, Michele;
    • Sorio, Roberto;
    • Bartoletti, Michele;
    • De Mattia, Elena;
    • Cecchin, Erika;
    • Pisano, Carmela;
    • Lorusso, Domenica;
    • Lissoni, Andrea Alberto;
    • De Censi, Andrea;
    • Cecere, Sabrina Chiara;
    • Scollo, Paolo;
    • Marchini, Sergio;
    • Arenare, Laura;
    • De Giorgi, Ugo;
    • Califano, Daniela;
    • Biagioli, Elena;
    • Chiodini, Paolo;
    • Perrone, Francesco
    Publication type:
    Article
    8

    A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 1021, doi. 10.1007/s00280-009-0958-0
    By:
    • Pisano, Carmela;
    • Morabito, Alessandro;
    • Sorio, Roberto;
    • Breda, Enrico;
    • Lauria, Rossella;
    • Gebbia, Vittorio;
    • Scaltriti, Laura;
    • Scalone, Simona;
    • Zagonel, Vittorina;
    • Greggi, Stefano;
    • Beneduce, Gerardo;
    • Losito, Simona;
    • Gallo, Ciro;
    • Di Maio, Massimo;
    • Forestieri, Valeria;
    • Pignata, Sandro
    Publication type:
    Article
    9
    10

    Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1846, doi. 10.1002/cncr.34706
    By:
    • Mirza, Mansoor R.;
    • González‐Martín, Antonio;
    • Graybill, Whitney S.;
    • O'Malley, David M.;
    • Gaba, Lydia;
    • Stephanie Yap, Oi Wah;
    • Guerra, Eva M.;
    • Rose, Peter G.;
    • Baurain, Jean‐François;
    • Ghamande, Sharad A.;
    • Denys, Hannelore;
    • Prendergast, Emily;
    • Pisano, Carmela;
    • Follana, Philippe;
    • Baumann, Klaus;
    • Calvert, Paula M.;
    • Korach, Jacob;
    • Li, Yong;
    • Malinowska, Izabela A.;
    • Gupta, Divya
    Publication type:
    Article
    11
    12

    Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.

    Published in:
    International Journal of Biological Markers, 2024, v. 39, n. 4, p. 328, doi. 10.1177/03936155241296164
    By:
    • Indraccolo, Stefano;
    • Signoriello, Simona;
    • Piga, Ilaria;
    • Esposito, Giovanni;
    • Ferrarini, Federica;
    • Boscolo Bragadin, Andrea;
    • Salutari, Vanda;
    • Pisano, Carmela;
    • Califano, Daniela;
    • Bignotti, Eliana;
    • Tognon, Germana;
    • Simeon, Vittorio;
    • Artioli, Grazia;
    • Ferrero, Annamaria;
    • Cinieri, Saverio;
    • Bologna, Alessandra;
    • Chiodini, Paolo;
    • Scognamiglio, Giosuè;
    • Bottoni, Carolina;
    • Spina, Anna
    Publication type:
    Article
    13

    Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.

    Published in:
    Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 44, doi. 10.1007/s00262-004-0567-z
    By:
    • Ottaiano, Alessandro;
    • Mollo, Ernesto;
    • Lorenzo, Giuseppe;
    • Pisano, Carmela;
    • Maio, Massimo;
    • Barletta, Emiddio;
    • Pensabene, Matilde;
    • Segati, Romana;
    • Bullian, Pierluigi;
    • Nasti, Guglielmo;
    • Bryce, Jane;
    • Scala, Stefania;
    • Castello, Giuseppe;
    • Ascierto, Paolo
    Publication type:
    Article
    14

    The prognostic role of miR-181a-5p in advanced stages epithelial ovarian cancer patients enrolled in MITO16A/MaNGO-OV2 clinical trial.

    Published in:
    European Journal of Gynaecological Oncology, 2025, v. 46, n. 6, p. 34, doi. 10.22514/ejgo.2025.078
    By:
    • Paracchini, Lara;
    • Zannoni, Gian Franco;
    • Arenare, Laura;
    • Spina, Anna;
    • De Cecco, Loris;
    • Scambia, Giovanni;
    • Gallo, Daniela;
    • Pisano, Carmela;
    • Califano, Daniela;
    • Ferrero, Annamaria;
    • Scognamiglio, Giosuè;
    • Cecere, Sabrina Chiara;
    • Russo, Daniela;
    • Schettino, Clorinda;
    • Mezzanzanica, Delia;
    • Breda, Enrico;
    • Chiodini, Paolo;
    • Biagioli, Elena;
    • Perrone, Francesco;
    • D’Incalci, Maurizio
    Publication type:
    Article
    15
    16

    Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880008
    By:
    • Giannone, Gaia;
    • Castaldo, Daniele;
    • Tuninetti, Valentina;
    • Scotto, Giulia;
    • Turinetto, Margherita;
    • Valsecchi, Anna Amela;
    • Bartoletti, Michele;
    • Mammoliti, Serafina;
    • Artioli, Grazia;
    • Mangili, Giorgia;
    • Salutari, Vanda;
    • Lorusso, Domenica;
    • Cormio, Gennaro;
    • Zamagni, Claudio;
    • Savarese, Antonella;
    • Di Maio, Massimo;
    • Ronzino, Graziana;
    • Pisano, Carmela;
    • Pignata, Sandro;
    • Valabrega, Giorgio
    Publication type:
    Article
    17

    PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.

    Published in:
    Cancer Management & Research, 2020, v. 12, p. 6123, doi. 10.2147/CMAR.S221001
    By:
    • Musacchio, Lucia;
    • Caruso, Giuseppe;
    • Pisano, Carmela;
    • Cecere, Sabrina Chiara;
    • Napoli, Marilena Di;
    • Attademo, Laura;
    • Tambaro, Rosa;
    • Russo, Daniela;
    • Califano, Daniela;
    • Palaia, Innocenza;
    • Muzii, Ludovico;
    • Panici, Pierluigi Benedetti;
    • Pignata, Sandro
    Publication type:
    Article
    18
    19

    Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).

    Published in:
    2022
    By:
    • Musacchio, Lucia;
    • Califano, Daniela;
    • Bartoletti, Michele;
    • Arenare, Laura;
    • Lorusso, Domenica;
    • Losito, Nunzia Simona;
    • Cormio, Gennaro;
    • Greggi, Stefano;
    • Raspagliesi, Francesco;
    • Valabrega, Giorgio;
    • Salutari, Vanda;
    • Pisano, Carmela;
    • Spina, Anna;
    • Russo, Daniela;
    • Del Sesto, Michele;
    • Canzonieri, Vincenzo;
    • Ferraù, Francesco;
    • Zannoni, Gian Franco;
    • Loizzi, Vera;
    • Ghizzoni, Viola
    Publication type:
    journal article
    20
    21

    Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
    By:
    • Schouten, Philip C.;
    • Schmidt, Sandra;
    • Becker, Kerstin;
    • Thiele, Holger;
    • Nürnberg, Peter;
    • Richters, Lisa;
    • Ernst, Corinna;
    • Treilleux, Isabelle;
    • Medioni, Jacques;
    • Heitz, Florian;
    • Pisano, Carmela;
    • Garcia, Yolanda;
    • Petru, Edgar;
    • Hietanen, Sakari;
    • Colombo, Nicoletta;
    • Vergote, Ignace;
    • Nagao, Shoji;
    • Linn, Sabine C.;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    22

    MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study

    Published in:
    Cancers, 2024, v. 16, n. 1, p. 41, doi. 10.3390/cancers16010041
    By:
    • Turinetto, Margherita;
    • Ricotti, Andrea;
    • Marchetti, Claudia;
    • Pisano, Carmela;
    • Zamagni, Claudio;
    • Cassani, Chiara;
    • Malaguti, Paola;
    • Baldoni, Alessandra;
    • Scollo, Paolo;
    • Scandurra, Giuseppa;
    • Parisi, Alessandro;
    • Artioli, Grazia;
    • Palaia, Innocenza;
    • Vertechy, Laura;
    • Bergamini, Alice;
    • Picardo, Elisa;
    • Tuninetti, Valentina;
    • Scotto, Giulia;
    • Scambia, Giovanni;
    • Pignata, Sandro
    Publication type:
    Article
    23

    Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1849, doi. 10.3390/cancers14071849
    By:
    • D'Alterio, Crescenzo;
    • Spina, Anna;
    • Arenare, Laura;
    • Chiodini, Paolo;
    • Napolitano, Maria;
    • Galdiero, Francesca;
    • Portella, Luigi;
    • Simeon, Vittorio;
    • Signoriello, Simona;
    • Raspagliesi, Francesco;
    • Lorusso, Domenica;
    • Pisano, Carmela;
    • Colombo, Nicoletta;
    • Zannoni, Gian Franco;
    • Losito, Nunzia Simona;
    • De Cecio, Rossella;
    • Scognamiglio, Giosuè;
    • Califano, Daniela;
    • Russo, Daniela;
    • Tuninetti, Valentina
    Publication type:
    Article
    24

    Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.

    Published in:
    BMC Cancer, 2006, v. 6, p. 202, doi. 10.1186/1471-2407-6-202
    By:
    • Pignata, Sandro;
    • Scambia, Giovanni;
    • Savarese, Antonella;
    • Breda, Enrico;
    • Scollo, Paolo;
    • De Vivo, Rocco;
    • Rossi, Emanuela;
    • Gebbia, Vittorio;
    • Natale, Donato;
    • Del Gaizo, Filomena;
    • Naglieri, Emanuele;
    • Ferro, Antonella;
    • Musso, Pietro;
    • D'Arco, Alfonso Maria;
    • Sorio, Roberto;
    • Pisano, Carmela;
    • Di Maio, Massimo;
    • Signoriello, Giuseppe;
    • Annunziata, Annalisa;
    • Perrone, Francesco
    Publication type:
    Article
    25

    Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.

    Published in:
    BMC Cancer, 2006, v. 6, p. 5, doi. 10.1186/1471-2407-6-5
    By:
    • Pignata, Sandro;
    • De Placido, Sabino;
    • Biamonte, Rosalbino;
    • Scambia, Giovanni;
    • Di Vagno, Giovanni;
    • Colucci, Giuseppe;
    • Febbraro, Antonio;
    • Marinaccio, Marco;
    • Lombardi, Alessandra Vernaglia;
    • Manzione, Luigi;
    • Cartení, Giacomo;
    • Nardi, Mario;
    • Danese, Saverio;
    • Valerio, Maria Rosaria;
    • de Matteis, Andrea;
    • Massidda, Bruno;
    • Gasparini, Giampietro;
    • Di Maio, Massimo;
    • Pisano, Carmela;
    • Perrone, Francesco
    Publication type:
    Article
    26

    Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.

    Published in:
    Diagnostics (2075-4418), 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/diagnostics12092118
    By:
    • Fabbi, Marina;
    • Costa, Delfina;
    • Russo, Daniela;
    • Arenare, Laura;
    • Gaggero, Gabriele;
    • Signoriello, Simona;
    • Scambia, Giovanni;
    • Pisano, Carmela;
    • Colombo, Nicoletta;
    • Losito, Nunzia Simona;
    • Filaci, Gilberto;
    • Spina, Anna;
    • Califano, Daniela;
    • Scognamiglio, Giosuè;
    • Gadducci, Angiolo;
    • Mezzanzanica, Delia;
    • Bagnoli, Marina;
    • Ferrini, Silvano;
    • Canzonieri, Vincenzo;
    • Chiodini, Paolo
    Publication type:
    Article
    27

    Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

    Published in:
    Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01140-9
    By:
    • Rossi, Ernesto;
    • Bersanelli, Melissa;
    • Gelibter, Alain Jonathan;
    • Borsellino, Nicolò;
    • Caserta, Claudia;
    • Doni, Laura;
    • Maruzzo, Marco;
    • Mosca, Alessandra;
    • Pisano, Carmela;
    • Verzoni, Elena;
    • Zucali, Paolo Andrea
    Publication type:
    Article
    28
    29

    FEZ1/LZTS1 protein expression in ovarian cancer.

    Published in:
    Journal of Cellular Physiology, 2010, v. 222, n. 2, p. 382, doi. 10.1002/jcp.21962
    By:
    • CALIFANO, DANIELA;
    • PIGNATA, SANDRO;
    • PISANO, CARMELA;
    • GREGGI, STEFANO;
    • LAURELLI, GIUSEPPE;
    • LOSITO, NUNZIA SIMONA;
    • OTTAIANO, ALESSANDRO;
    • GALLIPOLI, ADOLFO;
    • PASQUINELLI, ROSA;
    • DE SIMONE, VERONICA;
    • CIROMBELLA, ROBERTO;
    • FUSCO, ALFREDO;
    • CHIAPPETTA, GENNARO
    Publication type:
    Article
    30

    Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1247291
    By:
    • Arezzo, Francesca;
    • Giannone, Gaia;
    • Castaldo, Daniele;
    • Scotto, Giulia;
    • Tuninetti, Valentina;
    • Turinetto, Margherita;
    • Bartoletti, Michele;
    • Mammoliti, Serafina;
    • Artioli, Grazia;
    • Mangili, Giorgia;
    • Salutari, Vanda;
    • Lorusso, Domenica;
    • Cormio, Gennaro;
    • Loizzi, Vera;
    • Zamagni, Claudio;
    • Savarese, Antonella;
    • Di Maio, Massimo;
    • Ronzino, Graziana;
    • Pisano, Carmela;
    • Pignata, Sandro
    Publication type:
    Article
    31

    Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1247291
    By:
    • Arezzo, Francesca;
    • Giannone, Gaia;
    • Castaldo, Daniele;
    • Scotto, Giulia;
    • Tuninetti, Valentina;
    • Turinetto, Margherita;
    • Bartoletti, Michele;
    • Mammoliti, Serafina;
    • Artioli, Grazia;
    • Mangili, Giorgia;
    • Salutari, Vanda;
    • Lorusso, Domenica;
    • Cormio, Gennaro;
    • Loizzi, Vera;
    • Zamagni, Claudio;
    • Savarese, Antonella;
    • Di Maio, Massimo;
    • Ronzino, Graziana;
    • Pisano, Carmela;
    • Pignata, Sandro
    Publication type:
    Article
    32

    Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.953115
    By:
    • Passarelli, Anna;
    • Pisano, Carmela;
    • Cecere, Sabrina Chiara;
    • Di Napoli, Marilena;
    • Rossetti, Sabrina;
    • Tambaro, Rosa;
    • Ventriglia, Jole;
    • Gherardi, Federica;
    • Iannacone, Eva;
    • Venanzio, Sergio Setola;
    • Fiore, Francesco;
    • Bartoletti, Michele;
    • Scognamiglio, Giosuè;
    • Califano, Daniela;
    • Pignata, Sandro
    Publication type:
    Article